Caribou Biosciences, Inc.

Quarterly Report for period ending 2023-03-31

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Annual report to security holders

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

None

Certification by an exchange approving securities for listing

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Point72 Asset Management, L.P.: Major Shareholders

PFM Health Sciences, LP: Major Shareholders

Kanner Steven: Statement of changes in beneficial ownership of securities

BlackRock Inc.: Major Shareholders

STATE STREET CORP: Major Shareholders

Kelly Timothy P: Initial statement of beneficial ownership of securities

Kelly Timothy P: Initial statement of beneficial ownership of securities

Kelly Timothy P: Statement of changes in beneficial ownership of securities

Avidity Partners Management LP: Major Shareholders

Point72 Asset Management, L.P.: Major Shareholders

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Registration statement for specified transactions by certain issuers

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(4)

Filing under Securities Act Rules 163/433 of free writing prospectuses

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1

General form of registration statement for all companies including face-amount certificate companies

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.